Cost and Quality

"Cost and Quality" Main

Latest Morning Briefing Stories

Organ Transplants Are Up, but the Agency in Charge Is Under Fire

A two-year congressional investigation has identified troubling lapses in the nation’s organ transplant system. Blood types mismatched, diseased organs transplanted anyway, and — most often — organs lost or damaged before they can save a life.

No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare

Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.

The Debt Crisis That Sick Americans Can’t Avoid

The federal government is stepping in to assist student loan borrowers. But little public attention has been focused on what is — statistically, at least — a bigger, broader debt crisis in our country: An estimated 100 million people in the U.S., or 41% of all adults, are saddled with pernicious health care debt.

La crisis de deuda que los estadounidenses enfermos no pueden evitar

Poca atención pública se ha centrado en lo que es, al menos estadísticamente, una crisis de deuda más grande: se estima que 100 millones de personas, o el 41% de todos los adultos del país, tienen deudas de atención médica, en comparación con 42 millones con deuda estudiantil.

Watch: The Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings

KHN chief Washington correspondent Julie Rovner discusses the Senate Democrats’ plans to let Medicare negotiate some drug prices, cap out-of-pocket drug costs for seniors, and fund enhanced subsides for ACA marketplace health plans.